The first patient is prescribed the Actiste[®] solution in Qatar
Brighter AB (“Brighter” or “The Company”) today announced that Actiste®, for the first time, is prescribed to a patient living with diabetes in Qatar. Dr. Omar Mashhor at the Future Medical Center in Qatar who is the first physician in Qatar to prescribe the device is optimistic about Brighter’s offer, in terms of real-life data and other features. “It’s a pleasure to start using Actiste® with my patients in Qatar and be one of the first prescribers in the country. As a strong believer in the impact of innovative technologies on patients' adherence and quality of life, I believe that